Literature DB >> 10657755

Drug transport in the mammalian central nervous system: multiple complex systems. A critical analysis and commentary.

R Spector1.   

Abstract

The rate of entry into and distribution of drugs and endogenous substances within the mammalian central nervous system (CNS) depend on the peculiar anatomy of the blood-brain and blood-cerebrospinal fluid barriers, the physicochemical nature of the substance or drug, and in many cases, multiple, complex specialized carriers. This review summarizes a systemic methodological and integrative approach to understanding the pharmacokinetic behavior of many drugs in the CNS in the context of the CNS barrier systems, focusing on recent data, several broad principles and selected examples. Standards of proof for valid conclusions are emphasized. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10657755     DOI: 10.1159/000028349

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  14 in total

Review 1.  New technologies for drug delivery across the blood brain barrier.

Authors:  A V Kabanov; E V Batrakova
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

2.  Nanomedicine in the diagnosis and therapy of neurodegenerative disorders.

Authors:  A V Kabanov; H E Gendelman
Journal:  Prog Polym Sci       Date:  2007       Impact factor: 29.190

Review 3.  Enhanced prospects for drug delivery and brain targeting by the choroid plexus-CSF route.

Authors:  Conrad E Johanson; John A Duncan; Edward G Stopa; Andrew Baird
Journal:  Pharm Res       Date:  2005-07-22       Impact factor: 4.200

Review 4.  Therapeutic drug monitoring and pharmacogenetic tests as tools in pharmacovigilance.

Authors:  Eveline Jaquenoud Sirot; Jan Willem van der Velden; Katharina Rentsch; Chin B Eap; Pierre Baumann
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 5.  Micronutrient and urate transport in choroid plexus and kidney: implications for drug therapy.

Authors:  Reynold Spector; Conrad Johanson
Journal:  Pharm Res       Date:  2006-10-18       Impact factor: 4.200

Review 6.  Animal models of limbic epilepsies: what can they tell us?

Authors:  Douglas A Coulter; Dan C McIntyre; Wolfgang Löscher
Journal:  Brain Pathol       Date:  2002-04       Impact factor: 6.508

7.  Involvement of multidrug resistance associated protein 1 (Mrp1) in the efflux transport of 17beta estradiol-D-17beta-glucuronide (E217betaG) across the blood-brain barrier.

Authors:  Daisuke Sugiyama; Hiroyuki Kusuhara; Yong-Joo Lee; Yuichi Sugiyama
Journal:  Pharm Res       Date:  2003-09       Impact factor: 4.200

8.  Expression and functional involvement of organic anion transporting polypeptide subtype 3 (Slc21a7) in rat choroid plexus.

Authors:  Hiroyuki Kusuhara; Zhonggui He; Yoshinori Nagata; Yoshitane Nozaki; Takashi Ito; Hiroyuki Masuda; Peter J Meier; Takaaki Abe; Yuichi Sugiyama
Journal:  Pharm Res       Date:  2003-05       Impact factor: 4.200

9.  Sensory effects of intravenous cocaine on dopamine and non-dopamine ventral tegmental area neurons.

Authors:  P Leon Brown; Eugene A Kiyatkin
Journal:  Brain Res       Date:  2008-04-22       Impact factor: 3.252

Review 10.  Drug delivery systems for the treatment of ischemic stroke.

Authors:  Taiyoun Rhim; Dong Yun Lee; Minhyung Lee
Journal:  Pharm Res       Date:  2013-01-10       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.